<i>PRELP</i> Regulates Cell–Cell Adhesion and EMT and Inhibits Retinoblastoma Progression

Retinoblastoma (RB) is the most common intraocular pediatric cancer. Nearly all cases of RB are associated with mutations compromising the function of the <i>RB1</i> tumor suppressor gene. We previously demonstrated that <i>PRELP</i> is widely downregulated in various cancers...

Full description

Bibliographic Details
Main Authors: Jack Hopkins, Ken Asada, Alex Leung, Vasiliki Papadaki, Hongorzul Davaapil, Matthew Morrison, Tomoko Orita, Ryohei Sekido, Hirofumi Kosuge, M. Ashwin Reddy, Kazuhiro Kimura, Akihisa Mitani, Kouhei Tsumoto, Ryuji Hamamoto, Mandeep S. Sagoo, Shin-ichi Ohnuma
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Cancers
Subjects:
Online Access:https://www.mdpi.com/2072-6694/14/19/4926
_version_ 1797480041650585600
author Jack Hopkins
Ken Asada
Alex Leung
Vasiliki Papadaki
Hongorzul Davaapil
Matthew Morrison
Tomoko Orita
Ryohei Sekido
Hirofumi Kosuge
M. Ashwin Reddy
Kazuhiro Kimura
Akihisa Mitani
Kouhei Tsumoto
Ryuji Hamamoto
Mandeep S. Sagoo
Shin-ichi Ohnuma
author_facet Jack Hopkins
Ken Asada
Alex Leung
Vasiliki Papadaki
Hongorzul Davaapil
Matthew Morrison
Tomoko Orita
Ryohei Sekido
Hirofumi Kosuge
M. Ashwin Reddy
Kazuhiro Kimura
Akihisa Mitani
Kouhei Tsumoto
Ryuji Hamamoto
Mandeep S. Sagoo
Shin-ichi Ohnuma
author_sort Jack Hopkins
collection DOAJ
description Retinoblastoma (RB) is the most common intraocular pediatric cancer. Nearly all cases of RB are associated with mutations compromising the function of the <i>RB1</i> tumor suppressor gene. We previously demonstrated that <i>PRELP</i> is widely downregulated in various cancers and our in vivo and in vitro analysis revealed <i>PRELP</i> as a novel tumor suppressor and regulator of EMT. In addition, <i>PRELP</i> is located at chromosome 1q31.1, around a region hypothesized to be associated with the initiation of malignancy in RB. Therefore, in this study, we investigated the role of <i>PRELP</i> in RB through in vitro analysis and next-generation sequencing. Immunostaining revealed that <i>PRELP</i> is expressed in Müller glial cells in the retina. mRNA expression profiling of <i>PRELP<sup>−/−</sup></i> mouse retina and <i>PRELP</i>-treated RB cells found that <i>PRELP</i> contributes to RB progression via regulation of the cancer microenvironment, in which loss of <i>PRELP</i> reduces cell–cell adhesion and facilitates EMT. Our observations suggest that <i>PRELP</i> may have potential as a new strategy for RB treatment.
first_indexed 2024-03-09T21:55:24Z
format Article
id doaj.art-14cb1393977440db97494b5004378901
institution Directory Open Access Journal
issn 2072-6694
language English
last_indexed 2024-03-09T21:55:24Z
publishDate 2022-10-01
publisher MDPI AG
record_format Article
series Cancers
spelling doaj.art-14cb1393977440db97494b50043789012023-11-23T19:58:59ZengMDPI AGCancers2072-66942022-10-011419492610.3390/cancers14194926<i>PRELP</i> Regulates Cell–Cell Adhesion and EMT and Inhibits Retinoblastoma ProgressionJack Hopkins0Ken Asada1Alex Leung2Vasiliki Papadaki3Hongorzul Davaapil4Matthew Morrison5Tomoko Orita6Ryohei Sekido7Hirofumi Kosuge8M. Ashwin Reddy9Kazuhiro Kimura10Akihisa Mitani11Kouhei Tsumoto12Ryuji Hamamoto13Mandeep S. Sagoo14Shin-ichi Ohnuma15UCL Institute of Ophthalmology, University College London, London EC1V 9EL, UKCancer Translational Research Team, RIKEN Center for Advanced Intelligence Project, Tokyo 103-0027, JapanUCL Institute of Ophthalmology, University College London, London EC1V 9EL, UKUCL Institute of Ophthalmology, University College London, London EC1V 9EL, UKUCL Institute of Ophthalmology, University College London, London EC1V 9EL, UKUCL Institute of Ophthalmology, University College London, London EC1V 9EL, UKUCL Institute of Ophthalmology, University College London, London EC1V 9EL, UKUCL Institute of Ophthalmology, University College London, London EC1V 9EL, UKSchool of Engineering, The University of Tokyo, Tokyo 113-8656, JapanRetinoblastoma Unit, Barts Health NHS Trust, Royal London Hospital, London E1 1BB, UKDepartment of Ophthalmology, Yamaguchi University Graduate School of Medicine, Yamaguchi 755-8505, JapanDepartment of Respiratory Medicine, Graduate School of Medicine, The University of Tokyo, Tokyo 113-0033, JapanSchool of Engineering, The University of Tokyo, Tokyo 113-8656, JapanCancer Translational Research Team, RIKEN Center for Advanced Intelligence Project, Tokyo 103-0027, JapanUCL Institute of Ophthalmology, University College London, London EC1V 9EL, UKUCL Institute of Ophthalmology, University College London, London EC1V 9EL, UKRetinoblastoma (RB) is the most common intraocular pediatric cancer. Nearly all cases of RB are associated with mutations compromising the function of the <i>RB1</i> tumor suppressor gene. We previously demonstrated that <i>PRELP</i> is widely downregulated in various cancers and our in vivo and in vitro analysis revealed <i>PRELP</i> as a novel tumor suppressor and regulator of EMT. In addition, <i>PRELP</i> is located at chromosome 1q31.1, around a region hypothesized to be associated with the initiation of malignancy in RB. Therefore, in this study, we investigated the role of <i>PRELP</i> in RB through in vitro analysis and next-generation sequencing. Immunostaining revealed that <i>PRELP</i> is expressed in Müller glial cells in the retina. mRNA expression profiling of <i>PRELP<sup>−/−</sup></i> mouse retina and <i>PRELP</i>-treated RB cells found that <i>PRELP</i> contributes to RB progression via regulation of the cancer microenvironment, in which loss of <i>PRELP</i> reduces cell–cell adhesion and facilitates EMT. Our observations suggest that <i>PRELP</i> may have potential as a new strategy for RB treatment.https://www.mdpi.com/2072-6694/14/19/4926<i>PRELP</i>retinoblastomacell–cell adhesiondysplasiaEMT/MET
spellingShingle Jack Hopkins
Ken Asada
Alex Leung
Vasiliki Papadaki
Hongorzul Davaapil
Matthew Morrison
Tomoko Orita
Ryohei Sekido
Hirofumi Kosuge
M. Ashwin Reddy
Kazuhiro Kimura
Akihisa Mitani
Kouhei Tsumoto
Ryuji Hamamoto
Mandeep S. Sagoo
Shin-ichi Ohnuma
<i>PRELP</i> Regulates Cell–Cell Adhesion and EMT and Inhibits Retinoblastoma Progression
Cancers
<i>PRELP</i>
retinoblastoma
cell–cell adhesion
dysplasia
EMT/MET
title <i>PRELP</i> Regulates Cell–Cell Adhesion and EMT and Inhibits Retinoblastoma Progression
title_full <i>PRELP</i> Regulates Cell–Cell Adhesion and EMT and Inhibits Retinoblastoma Progression
title_fullStr <i>PRELP</i> Regulates Cell–Cell Adhesion and EMT and Inhibits Retinoblastoma Progression
title_full_unstemmed <i>PRELP</i> Regulates Cell–Cell Adhesion and EMT and Inhibits Retinoblastoma Progression
title_short <i>PRELP</i> Regulates Cell–Cell Adhesion and EMT and Inhibits Retinoblastoma Progression
title_sort i prelp i regulates cell cell adhesion and emt and inhibits retinoblastoma progression
topic <i>PRELP</i>
retinoblastoma
cell–cell adhesion
dysplasia
EMT/MET
url https://www.mdpi.com/2072-6694/14/19/4926
work_keys_str_mv AT jackhopkins iprelpiregulatescellcelladhesionandemtandinhibitsretinoblastomaprogression
AT kenasada iprelpiregulatescellcelladhesionandemtandinhibitsretinoblastomaprogression
AT alexleung iprelpiregulatescellcelladhesionandemtandinhibitsretinoblastomaprogression
AT vasilikipapadaki iprelpiregulatescellcelladhesionandemtandinhibitsretinoblastomaprogression
AT hongorzuldavaapil iprelpiregulatescellcelladhesionandemtandinhibitsretinoblastomaprogression
AT matthewmorrison iprelpiregulatescellcelladhesionandemtandinhibitsretinoblastomaprogression
AT tomokoorita iprelpiregulatescellcelladhesionandemtandinhibitsretinoblastomaprogression
AT ryoheisekido iprelpiregulatescellcelladhesionandemtandinhibitsretinoblastomaprogression
AT hirofumikosuge iprelpiregulatescellcelladhesionandemtandinhibitsretinoblastomaprogression
AT mashwinreddy iprelpiregulatescellcelladhesionandemtandinhibitsretinoblastomaprogression
AT kazuhirokimura iprelpiregulatescellcelladhesionandemtandinhibitsretinoblastomaprogression
AT akihisamitani iprelpiregulatescellcelladhesionandemtandinhibitsretinoblastomaprogression
AT kouheitsumoto iprelpiregulatescellcelladhesionandemtandinhibitsretinoblastomaprogression
AT ryujihamamoto iprelpiregulatescellcelladhesionandemtandinhibitsretinoblastomaprogression
AT mandeepssagoo iprelpiregulatescellcelladhesionandemtandinhibitsretinoblastomaprogression
AT shinichiohnuma iprelpiregulatescellcelladhesionandemtandinhibitsretinoblastomaprogression